ELI LILLY AND COMPANY |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 787 USD | +3.02% |
|
+1.55% | +35.01% |
| 09:25am | Roche shares gain on obesity drug results from early-stage trial | RE |
| 06:41am | US Senate Committee Warns of Potential Healthcare Bankruptcy Due to Novo Nordisk's Wegovy | MT |
Presenter SpeechSteve Scala (Analysts)Good morning. I'd like to welcome Eli Lilly to Cowen's 4...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
787
USD
Average target price
850.4
USD
Spread / Average Target
+8.05%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +35.01% | 709B | |
| +30.65% | 595B | |
| -2.60% | 367B | |
| +20.83% | 334B | |
| +5.69% | 289B | |
| +14.57% | 239B | |
| +9.41% | 211B | |
| -3.60% | 203B | |
| +10.77% | 171B | |
| +0.10% | 163B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Transcript : Eli Lilly and Company Presents at 42nd Annual Cowen Health Care Conference, Mar-08-2022 10
